5-YEAR
SURVIVAL RATE
FOR SCLC
IS 9%*
*Based on data from SEER 2015-2021.
National Cancer Institute. SEER*Explorer. Small cell carcinoma of the lung and bronchus. Updated July 2, 2025. Accessed December 2, 2025. https://seer.cancer.gov/statistics-network/explorer/application.html
Discover Advances in 1L Maintenance
~75% OR MORE
OF PATIENTS
WITH SCLC
RELAPSE*
*~75% of patients with locally advanced disease
and >90% of patients with metastatic disease
progress within 2 years of treatment.
Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer.
Nat Rev Dis Primers. 2021;7(1):3. doi:10.1038/s41572-020-00235-0
Discover Advances in 1L Maintenance
Only ~40% of 1L
patients go on TO
receive 2L
TREATMENT1,2*
*SHS claims data ending September 2024; Tx Onc data
ending October 2024; Onmark Unity Data ending
October 2024; IntrinsiQ ION data ending October 2024.
References: 1. Cramer-van der Welle CM, Schramel FMNH, van Leeuwen AS, Groen HJM, van de Garde EMW; Santeon SCLC Study Group. Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer. Eur J Cancer Care (Engl). 2020;29(5):e13250. doi:10.1111/ecc.13250 2. Data on file-REF-21246. Palo Alto, CA: Jazz Pharmaceuticals, Inc.
Discover Advances in 1L Maintenance
Maintaining momentum is possible.
Learn about expanding options to delay relapse after induction.
1L TREATMENT- Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3. doi:10.1038/s41572-020-00235-0
- Byers LA, Rudin CM. Small cell lung cancer: where do we go from here? Cancer. 2015;121(5):664-672.
- Huber RM, Tufman A. Update on small cell lung cancer management. Breathe. 2012;8(4):314-330.
- Small cell lung cancer stages. American Cancer Society. https://www.cancer.org/cancer/lung-cancer/detection-diagnosis-staging/staging-sclc.html. Accessed March 25, 2025.
1L=first-line; 2L=second-line; SCLC=small cell lung cancer.
REFERENCES: